Annual Operating Profit
-$142.34 M
+$61.22 M+30.08%
December 31, 2023
Summary
- As of February 8, 2025, FBIO annual operating income is -$142.34 million, with the most recent change of +$61.22 million (+30.08%) on December 31, 2023.
- During the last 3 years, FBIO annual operating profit has fallen by -$48.07 million (-50.99%).
- FBIO annual operating profit is now -1440.33% below its all-time high of -$9.24 million, reached on December 31, 2010.
Performance
FBIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$22.09 M
+$3.04 M+12.11%
September 30, 2024
Summary
- As of February 8, 2025, FBIO quarterly operating income is -$22.09 million, with the most recent change of +$3.04 million (+12.11%) on September 30, 2024.
- Over the past year, FBIO quarterly operating profit has dropped by -$8.34 million (-60.60%).
- FBIO quarterly operating profit is now -961.24% below its all-time high of -$2.08 million, reached on September 30, 2010.
Performance
FBIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$106.56 M
-$8.34 M-8.49%
September 30, 2024
Summary
- As of February 8, 2025, FBIO TTM operating income is -$106.56 million, with the most recent change of -$8.34 million (-8.49%) on September 30, 2024.
- Over the past year, FBIO TTM operating profit has increased by +$67.66 million (+38.84%).
- FBIO TTM operating profit is now -5018.01% below its all-time high of -$2.08 million, reached on September 30, 2010.
Performance
FBIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
FBIO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.1% | -60.6% | +38.8% |
| 3 y3 years | -51.0% | +64.4% | +39.2% |
| 5 y5 years | -18.6% | +4.1% | -6.2% |
FBIO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.1% | -60.6% | +64.4% | -8.5% | +50.5% |
| 5 y | 5-year | -51.0% | +30.1% | -60.6% | +64.4% | -13.0% | +50.5% |
| alltime | all time | -1440.3% | +30.1% | -961.2% | +64.4% | -5018.0% | +50.5% |
Fortress Biotech Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$22.09 M(-12.1%) | -$106.56 M(+8.5%) |
| Jun 2024 | - | -$25.14 M(-31.3%) | -$98.22 M(-18.2%) |
| Mar 2024 | - | -$36.57 M(+60.7%) | -$120.04 M(-15.7%) |
| Dec 2023 | -$142.34 M(-30.1%) | -$22.76 M(+65.4%) | -$142.34 M(-18.3%) |
| Sep 2023 | - | -$13.76 M(-70.7%) | -$174.22 M(-17.5%) |
| Jun 2023 | - | -$46.96 M(-20.2%) | -$211.20 M(-1.8%) |
| Mar 2023 | - | -$58.87 M(+7.7%) | -$215.16 M(+5.7%) |
| Dec 2022 | -$203.56 M(+13.7%) | -$54.63 M(+7.7%) | -$203.56 M(-3.5%) |
| Sep 2022 | - | -$50.73 M(-0.4%) | -$210.93 M(+5.2%) |
| Jun 2022 | - | -$50.93 M(+7.7%) | -$200.58 M(+4.2%) |
| Mar 2022 | - | -$47.27 M(-23.8%) | -$192.51 M(+9.8%) |
| Dec 2021 | -$179.00 M(+89.9%) | -$62.00 M(+53.5%) | -$175.26 M(+27.4%) |
| Sep 2021 | - | -$40.38 M(-5.8%) | -$137.56 M(+14.4%) |
| Jun 2021 | - | -$42.86 M(+42.8%) | -$120.22 M(+17.0%) |
| Mar 2021 | - | -$30.02 M(+23.5%) | -$102.76 M(+9.0%) |
| Dec 2020 | -$94.27 M(-14.9%) | -$24.30 M(+5.5%) | -$94.27 M(-6.1%) |
| Sep 2020 | - | -$23.04 M(-9.3%) | -$100.35 M(+0.5%) |
| Jun 2020 | - | -$25.40 M(+18.0%) | -$99.84 M(+0.1%) |
| Mar 2020 | - | -$21.53 M(-29.1%) | -$99.74 M(-10.0%) |
| Dec 2019 | -$110.82 M(-7.6%) | -$30.38 M(+34.8%) | -$110.82 M(-1.6%) |
| Sep 2019 | - | -$22.54 M(-10.9%) | -$112.66 M(-4.8%) |
| Jun 2019 | - | -$25.29 M(-22.4%) | -$118.33 M(-0.1%) |
| Mar 2019 | - | -$32.61 M(+1.2%) | -$118.43 M(-1.3%) |
| Dec 2018 | -$120.00 M(+33.6%) | -$32.22 M(+14.2%) | -$120.00 M(+15.2%) |
| Sep 2018 | - | -$28.20 M(+11.1%) | -$104.20 M(-4.0%) |
| Jun 2018 | - | -$25.40 M(-25.7%) | -$108.60 M(+2.1%) |
| Mar 2018 | - | -$34.17 M(+108.1%) | -$106.39 M(+18.5%) |
| Dec 2017 | -$89.80 M | -$16.42 M(-49.6%) | -$89.80 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$32.60 M(+40.6%) | -$92.61 M(+21.5%) |
| Jun 2017 | - | -$23.19 M(+32.0%) | -$76.25 M(+11.8%) |
| Mar 2017 | - | -$17.58 M(-8.6%) | -$68.20 M(+3.8%) |
| Dec 2016 | -$65.71 M(+30.0%) | -$19.24 M(+18.4%) | -$65.71 M(+11.2%) |
| Sep 2016 | - | -$16.25 M(+7.3%) | -$59.10 M(-3.0%) |
| Jun 2016 | - | -$15.14 M(+0.3%) | -$60.92 M(+13.8%) |
| Mar 2016 | - | -$15.09 M(+19.5%) | -$53.55 M(+6.0%) |
| Dec 2015 | -$50.53 M(+144.7%) | -$12.63 M(-30.1%) | -$50.53 M(+17.9%) |
| Sep 2015 | - | -$18.07 M(+132.8%) | -$42.87 M(+47.1%) |
| Jun 2015 | - | -$7.76 M(-35.7%) | -$29.14 M(+11.5%) |
| Mar 2015 | - | -$12.07 M(+143.3%) | -$26.14 M(+26.6%) |
| Dec 2014 | -$20.65 M(-42.3%) | -$4.96 M(+14.2%) | -$20.65 M(-18.1%) |
| Sep 2014 | - | -$4.35 M(-8.8%) | -$25.21 M(-11.1%) |
| Jun 2014 | - | -$4.76 M(-27.6%) | -$28.37 M(-16.3%) |
| Mar 2014 | - | -$6.58 M(-30.9%) | -$33.90 M(-5.2%) |
| Dec 2013 | -$35.78 M(+31.7%) | -$9.52 M(+26.9%) | -$35.78 M(+3.5%) |
| Sep 2013 | - | -$7.50 M(-27.1%) | -$34.55 M(+5.1%) |
| Jun 2013 | - | -$10.29 M(+21.7%) | -$32.88 M(+13.2%) |
| Mar 2013 | - | -$8.46 M(+1.9%) | -$29.05 M(+6.9%) |
| Dec 2012 | -$27.18 M(-22.5%) | -$8.30 M(+42.3%) | -$27.18 M(+12.7%) |
| Sep 2012 | - | -$5.83 M(-9.8%) | -$24.11 M(+10.5%) |
| Jun 2012 | - | -$6.46 M(-1.8%) | -$21.81 M(+14.3%) |
| Mar 2012 | - | -$6.58 M(+25.8%) | -$19.08 M(-45.6%) |
| Dec 2011 | -$35.04 M(+279.2%) | -$5.23 M(+48.2%) | -$35.04 M(+8.8%) |
| Sep 2011 | - | -$3.53 M(-5.5%) | -$32.20 M(+4.7%) |
| Jun 2011 | - | -$3.74 M(-83.4%) | -$30.75 M(+13.8%) |
| Mar 2011 | - | -$22.55 M(+843.3%) | -$27.02 M(+504.1%) |
| Dec 2010 | -$9.24 M | -$2.39 M(+14.8%) | -$4.47 M(+114.8%) |
| Sep 2010 | - | -$2.08 M | -$2.08 M |
FAQ
- What is Fortress Biotech annual operating income?
- What is the all time high annual operating profit for Fortress Biotech?
- What is Fortress Biotech annual operating profit year-on-year change?
- What is Fortress Biotech quarterly operating income?
- What is the all time high quarterly operating profit for Fortress Biotech?
- What is Fortress Biotech quarterly operating profit year-on-year change?
- What is Fortress Biotech TTM operating income?
- What is the all time high TTM operating profit for Fortress Biotech?
- What is Fortress Biotech TTM operating profit year-on-year change?
What is Fortress Biotech annual operating income?
The current annual operating profit of FBIO is -$142.34 M
What is the all time high annual operating profit for Fortress Biotech?
Fortress Biotech all-time high annual operating income is -$9.24 M
What is Fortress Biotech annual operating profit year-on-year change?
Over the past year, FBIO annual operating income has changed by +$61.22 M (+30.08%)
What is Fortress Biotech quarterly operating income?
The current quarterly operating profit of FBIO is -$22.09 M
What is the all time high quarterly operating profit for Fortress Biotech?
Fortress Biotech all-time high quarterly operating income is -$2.08 M
What is Fortress Biotech quarterly operating profit year-on-year change?
Over the past year, FBIO quarterly operating income has changed by -$8.34 M (-60.60%)
What is Fortress Biotech TTM operating income?
The current TTM operating profit of FBIO is -$106.56 M
What is the all time high TTM operating profit for Fortress Biotech?
Fortress Biotech all-time high TTM operating income is -$2.08 M
What is Fortress Biotech TTM operating profit year-on-year change?
Over the past year, FBIO TTM operating income has changed by +$67.66 M (+38.84%)